Condition: Familial Melanoma · Fear of Cancer Recurrence · Eye Movement Desensitization and Reprocessing · Sponsor: Leiden University Medical Center
High fear of cancer recurrence (FCR) impacts patient's quality of life (QoL) and is prevalent among patients with familial melanoma. The main objective is to investigate whether EMDR is effective in treating high FCR in patients with familial melanoma. The study design is a non-blinded, randomized waiting-list controlled trial. Patients aged 18 years or older with familial melanoma can be included. Patients with high FCR will receive a maximum of 4, 90 minutes, EMDR-sessions. The main study parameter is the decrease and level of FCR measured with the Cancer Worry Scale (CWS). The secondary study parameter is quality of life, measured with the EORTC.
This description comes directly from the study's public registry record.
Sanne K. de Bie, Drs. · 0031 71 526 3615 · s.k.de_bie@lumc.nl
Chris Hinnen, Dr. · 0031 71 526 3615 · s.c.h.hinnen@lumc.nl
Always discuss trial participation with your own doctor first.
| Leiden University Medical Center | Leiden, South Holland, Netherlands | Recruiting |
| Leiden University Medical Centre | Leiden, South Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06767332